Alfa Biotechnology

Alfa Biotechnology is a Turkish life sciences company specializing in the development and manufacture of molecular diagnostic solutions and biotechnological reagents. The company is a prominent provider of Real-Time PCR kits, nucleic acid extraction systems, and viral transport media, primarily serving the clinical and research sectors. Alfa Biotechnology gained significant international visibility during the COVID-19 pandemic for its rapid production of diagnostic tools and its participation in national vaccine development initiatives. Their product portfolio, marketed under the 'Alfa-Q' brand, covers a wide range of infectious diseases, oncology, and genetic testing. The company is committed to advancing molecular diagnostics through innovative R&D and strategic partnerships with academic and governmental institutions.